Moderna, Inc. MRNA

198.88 4.06 2.08% as of 25 Sep
Market cap
$78.8B
P/E
0.0×
Indexes indicate stock being part of an index

Moderna, Inc. (MRNA) Book value per share

Moderna, Inc.'s book value per share at the end of fiscal 2025 was 22.2×, down 21.7% from 28.4× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 17.0×. Over the past ten years it has ranged from −8.5× (fiscal 2017) to 48.5× (fiscal 2022); the current reading is higher than 60% of that period. Moderna, Inc. ranks 37th of 614 Biotechnology companies by book value per share.

Book value per share, annual

Annual

Period Book value per share Change
FY2025 22.2× (21.67%)
FY2024 28.4× (21.72%)
FY2023 36.3× (25.28%)
FY2022 48.5× 38.28%
FY2021 35.1× 422.17%
FY2020 6.7× 89.38%
FY2019 3.5× (81.19%)
FY2018 18.9× —
FY2017 −8.5× —
FY2016 −5.5× —

Quarterly

Period Book value per share Change
Jun 2026 17.0× (9.42%)
Mar 2026 18.8× (15.66%)
Dec 2025 22.2× (7.05%)
Sep 2025 23.9× (1.24%)
32 more quarters

Against its own ten years

Low −8.5× High 48.5×
Ten-year median 20.6×
Current reading's percentile 60

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on MRNA